Navigation Links
PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
Date:12/7/2012

Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect PROLOR's business and prospects, including the risks that PROLOR may not succeed in generating any revenues or developing any commercial products, including any long-acting versions of human growth hormone, erythropoietin, interferon beta, GLP-1 and other products; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from Israel's Office of the Chief Scientist is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The results of clinical trials in humans may produce results that differ significantly from the results of clinical and other trials in animals. The results of early-stage trials may differ significantly from the results of more developed, later-stage trials. The development of any products using the CTP platform technology could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties.  In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchang
'/>"/>
SOURCE PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GenWay Biotech Appoints New Vice President of Custom/OEM
2. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
7. Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June
8. Tougher Times May be Ahead for Biotechs: 1H12 Fundraising Slows
9. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Lifeline Biotechnologies First Warning Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... ALBANY, New York , July 11, 2014 /PRNewswire/ ... published by Transparency Market Research "Endoscopy Devices Market (Endoscopes, ... Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019" the ... billion in 2012 and is expected to grow at ... reach an estimated value of USD 36.9 billion in ...
(Date:7/11/2014)... , July 11, 2014 ... to Safety & Health Expo 2014 were ... move to London , ... attending exhibition.          ... http://photos.prnewswire.com/prnh/20140711/696892-a )      (Photo: ...
(Date:7/10/2014)... , 11. Juli 2014  Dilon ... für die molekulare Bildgebung, einschließlich molekularer ... die CE-Zulassung für sein Navigator ® ... Dilon das Produkt jetzt europaweit vertreiben. ... Großteil der europäischen Länder ausgedehnt und ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
... BellaNovus Development Company LLC, a medical design ... the Ouchless™ Needle Collection. The devices provide doctors ... creams and ice currently used to minimize localized ... and dermal fillers. Offered in three models, Ouchless™ ...
... CIVCO Medical Solutions is showcasing its RFSuite RFID tracking ... also hosting an RFSuite Symposium Monday, August 1st, from ... the Fairmont Waterfront, Vancouver. The event will include lunch, ... Click here to view the invitation and register . ...
Cached Medicine Technology:New Ouchless™ Needle Collection Revolutionizes Wrinkle Treatments With State-of-the-Art Pain Reducing Technology 2CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817 2CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817 3
(Date:7/14/2014)... York, NY (PRWEB) July 14, 2014 ... app on iTunes, called Love Digits. The App brings ... and couples alike to quantify their compatibility using a ... and places, two people can instantaneously test their compatibility ... Chinese astrology measures. , The app’s five-star rating system ...
(Date:7/14/2014)... New research and analysis from the ... Earth examines toxic ingredients in tampons, a product ... specific chemicals that may be found in the product’s ... may put women’s health at risk. , According ... Scranton , the potential impact of toxic chemical exposure ...
(Date:7/13/2014)... Recently, MagicQuinceaneraDresses.com, a well-known special occasion dress manufacturer and ... Dama dresses . Furthermore, the company’s sales manager has ... sale. They are available at greatly discounted prices, up ... to unveil the cheap, fashionable Dama gowns. “By launching ... for our fans. It will last until July 26. ...
(Date:7/13/2014)... Denver, CO (PRWEB) July 13, 2014 ... in conjunction with the 2014 Guinness International Champions Cup. ... on American soil each year because of the talent of ... Manchester United and AS Roma will compete in the 2014 ... off on July 24 with a game between Olympiacos and ...
(Date:7/13/2014)... Failure to get the best treatment and variations in ... why survival for blood cancer patients still varies widely ... study of survival in European adults to date, published ... news is that 5-year survival for most cancers of ... most likely reflecting the approval of new targeted drugs ...
Breaking Medicine News(10 mins):Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 4Health News:New Patent Analysis Shows Toxic Risk From Tampons 5Health News:Fashionable Dama Dresses Unveiled By Well-known Supplier MagicQuinceaneraDresses.com 2Health News:Manchester United vs. AS Roma Tickets in Denver, CO at Sports Authority Field at Mile High: Ticket Down Slashes Ticket Prices on International Champions Cup in Denver 2Health News:Manchester United vs. AS Roma Tickets in Denver, CO at Sports Authority Field at Mile High: Ticket Down Slashes Ticket Prices on International Champions Cup in Denver 3Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 3
... , SATURDAY, June 4 (HealthDay News) -- Breast cancer ... diagnosis have a lower chance of surviving, a new study ... cancer and obesity only in estrogen receptor-positive forms of the ... breast cancer. "This relationship between dying and being obese ...
... a healthy body weight before and after diagnosis of breast ... a new study finds. The results will be presented Saturday ... The study, conducted in nearly 4,000 breast cancer survivors, found ... cancer. In particular, overweight or obese women with a history ...
... radiation treatment improves disease free survival lessening the chance ... who have had breast conserving surgery (lumpectomy), interim results ... presented Monday, June 6 at the annual meeting of ... results are potentially practice-changing," said Dr. Timothy J. Whelan, ...
... Reporter , FRIDAY, June 3 (HealthDay News) -- Early ... the cancer,s return drop by 32 percent when the ... for three years after surgery, Austrian researchers report. ... to develop osteoporosis, so they are usually given a ...
... June 3 (HealthDay News) -- Providing children with more toys ... researchers say. The new study also found that having ... play among children, particularly girls. In the ... of Buffalo in New York, researchers offered three different quantities ...
... M.D., Ph.D. , the associate director of the Acute and ... a Career Development Award from the Conquer Cancer Foundation of the ... Foundation) at the annual ASCO meeting this weekend in ... at the Mayo Clinic News Blog . Dr. ...
Cached Medicine News:Health News:Excess Pounds May Lower Odds of Surviving Breast Cancer 2Health News:Obesity raises breast cancer survivors' risk of dying of the cancer 2Health News:Breast cancer surgery patients benefit from adding radiation therapy 2Health News:Bone Drug Reduces Odds for Breast Cancer's Return: Study 2Health News:Bone Drug Reduces Odds for Breast Cancer's Return: Study 3Health News:Having More Toys May Boost Exercise Levels in Kids 2Health News:Mayo Clinic: Raoul Tibes, M.D., Ph.D., to receive Career Development Award 2
... Easy Breeze Air Gel Dryer : Dry up ... 24 gels 8 10 cm without a ... rapid drying, or no heat for controlled drying ... transparent, dried gels. Add and remove gels at ...
Each GelAir™ system drying frame includes two main components, a plastic drying outer frame and a metal square inner frame, as well as 8 clamps per frame. Supplied as a set of two frames....
... Breeze Air Gel Dryer : Dry up to ... gels 8 10 cm without a vacuum ... drying, or no heat for controlled drying of ... dried gels. Add and remove gels at any ...
... SGD5040 Slab Gel Dryer incorporates sturdy metal housing and ... The large surface area makes it perfect for drying ... Slim Profile 40cm x 50cm (W x D) ... Rates allows you to optimize your heating ...
Medicine Products: